Search - tctmd.com

Displaying 681 - 700 of 1061

Sort: Relevancy | Date

News Daily News

PARTNER Subanalysis Examines Effect of Annulus Size on Valve Hemodynamics, Outcomes

Yael L. Maxwell

October 10, 2014

News Daily News

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

October 10, 2014

News Daily News

Datos del PARTNER ofrecen Más Evidencias del Impacto de la Mortalidad sobre la Regurgitación Post-TAVR

October 10, 2014

News Daily News

采用外科手术时的人工瓣膜不匹配率高于TAVR，导致更差结果

October 03, 2014

News Daily News

More Prosthesis-Patient Mismatch with Surgery vs TAVR, Linked to Worse Outcomes

October 03, 2014

News Daily News

La Mayor Discordancia Prótesis-Paciente de la Cirugía frente a la TAVR se asoció a Peores Resultados

October 03, 2014

News Industry News

Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System

September 23, 2014

News Conference News TCT 2014

Views Differ on Future of Percutaneous Mitral Valve Therapies

September 16, 2014

News Industry News

REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System

September 15, 2014

News Conference News TCT 2014

New Devices May Help Overcome the Issue of Paravalvular Regurgitation After TAVR

September 15, 2014

News Conference News TCT 2014

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

September 15, 2014

News Conference News TCT 2014

TCT Course Director Outlines Current TAVR Controversies

September 14, 2014

News Conference News TCT 2014

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

September 14, 2014

News Conference News TCT 2014

PARTNER: Post-TAVR Survival Higher in Overweight, Obese Patients

September 14, 2014

News Conference News TCT 2014

Lively Debate on Use of TAVR for Lower-Risk Patients

September 14, 2014

News Conference News TCT 2014

TAVR Effective in High-Risk Patients at ‘Acceptable’ Cost

Todd Neale

September 13, 2014

News Industry News

Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data

September 13, 2014

News Conference News TCT 2014

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Yael L. Maxwell

September 13, 2014

News Industry News

New Study Compares Cost-Effectiveness of Transcatheter Aortic Valve Replacement with Surgical Valve Replacement in High Risk Patients

September 13, 2014

News Conference News TCT 2014

Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk

September 13, 2014

Advertisement

PARTNER Subanalysis Examines Effect of Annulus Size on Valve Hemodynamics, Outcomes

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

Datos del PARTNER ofrecen Más Evidencias del Impacto de la Mortalidad sobre la Regurgitación Post-TAVR

采用外科手术时的人工瓣膜不匹配率高于TAVR，导致更差结果

More Prosthesis-Patient Mismatch with Surgery vs TAVR, Linked to Worse Outcomes

La Mayor Discordancia Prótesis-Paciente de la Cirugía frente a la TAVR se asoció a Peores Resultados

Boston Scientific Enrolls First Patients In U.S. Trial Of The Lotus™ Valve System

Views Differ on Future of Percutaneous Mitral Valve Therapies

REPRISE II Data Demonstrate Sustained Safety And Performance Outcomes At One Year For The Boston Scientific Lotus™ Valve System

New Devices May Help Overcome the Issue of Paravalvular Regurgitation After TAVR

Capture Devices Hold Promise for Decreasing TAVR-Related Stroke

TCT Course Director Outlines Current TAVR Controversies

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

PARTNER: Post-TAVR Survival Higher in Overweight, Obese Patients

Lively Debate on Use of TAVR for Lower-Risk Patients

TAVR Effective in High-Risk Patients at ‘Acceptable’ Cost

Significant Patient Benefits With Edwards SAPIEN Valve Demonstrated In 5-Year PARTNER Trial Data

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

New Study Compares Cost-Effectiveness of Transcatheter Aortic Valve Replacement with Surgical Valve Replacement in High Risk Patients

Moderate-to-Severe AR After TAVR May Yield Greater Mortality Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content